Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in tumours of the central nervous system.
- 1 August 1969
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 32 (4) , 324-327
- https://doi.org/10.1136/jnnp.32.4.324
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- THE CEREBROSPINAL-FLUID GLUTAMIC OXALOACETIC TRANSAMINASE ACTIVITY IN NEUROLOGICAL DISEASESThe Lancet, 1964
- Inhibition of dehydrogenase reactions by a substance formed from reduced diphosphopyridine nucleotideBiochimica et Biophysica Acta, 1961
- Effect of prolonged hypoxia on cerebrospinal fluid and plasma activity of GOT and LDHNeurology, 1961
- Cerebrospinal fluid‐glutamic oxalacetic acid transaminase in patients receiving electroconvulsive therapy and in neurologic diseasesNeurology, 1960
- Glutamic oxalacetic transaminase (GOT) and lactic dehydrogenase (LDH) activitiesNeurology, 1959
- Cerebrospinal Fluid Transaminase and Lactic Dehydrogenase Activities in Neurologic DiseaseArchives of Neurology & Psychiatry, 1958
- Lactic Dehydrogenase of Cerebrospinal Fluid in the Differential Diagnosis of Cerebrovascular Disease and Brain TumorJournal of Neurosurgery, 1958
- Glutamic‐Oxalacetic Transaminase Activity in Spinal FluidNeurology, 1957
- Cerebrospinal Fluid Glutamic Oxalacetic Transaminase Activity in Neurologic DiseaseNeurology, 1957
- Lactic Dehydrogenase Activity in Blood.Experimental Biology and Medicine, 1955